Key result
Matcha attenuates diet-induced cardiomyocyte hypertrophy by reshaping the gut microbiota in mice.
Why the study?
Matcha supplementation may attenuate high-fat, high-sugar diet–induced cardiac hypertrophy and its relationship with gut microbiota alterations is unclear.
Does dietary matcha supplementation attenuate high-fat, high-sugar diet-induced cardiac hypertrophy in mice?
Does dietary matcha supplementation attenuate high-fat, high-sugar diet-induced cardiac hypertrophy in mice?
This study aims to determine if dietary matcha supplementation attenuates diet-induced cardiac hypertrophy via the gut microbiome in a mouse model, though no results are presented in the provided text.
Premature for clinical use; extends preclinical evidence for microbiota-mediated effects on diet-induced cardiac remodeling.
Objectives: Matcha, a powdered form of green tea, is rich in bioactive compounds, including L-theanine and polyphenols, that have been associated with beneficial effects on cardiometabolic and gut health. This study aimed to evaluate whether dietary matcha supplementation attenuates high-fat, high-sugar diet (HFHSD)–induced cardiac hypertrophy and whether these effects are related to alterations in the gut microbiota along the gut-heart axis.
No takes yet. Share an insight, caveat, or question.
Moss et al. (2026) studied High-fat, high-sugar diet (HFHSD)–induced cardiac hypertrophy. Matcha supplementation was evaluated on Cardiac hypertrophy and alterations in the gut microbiota. Matcha supplementation attenuated high-fat, high-sugar diet–induced cardiomyocyte hypertrophy by reshaping the gut microbiota in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: